María Martín Cerezuela, Fernando Becerril Moreno, Miguel Ángel Amor García, Carla Bastida Fernández, Irene Aquerreta González, Sara Cobo Sacristán, Amaia Egüés Lugea, Marta Albanell Fernández, Laura Doménech Moral, Aurora Fernández Polo, Tatiana Betancor García, Sara Ortiz Pérez, Esther Domingo Chiva
{"title":"重症监护室药物干预的国家记录和分析:PHARMACRITIC 研究。","authors":"María Martín Cerezuela, Fernando Becerril Moreno, Miguel Ángel Amor García, Carla Bastida Fernández, Irene Aquerreta González, Sara Cobo Sacristán, Amaia Egüés Lugea, Marta Albanell Fernández, Laura Doménech Moral, Aurora Fernández Polo, Tatiana Betancor García, Sara Ortiz Pérez, Esther Domingo Chiva","doi":"10.1016/j.farma.2024.05.008","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To design a homogeneous methodology for the registration and analysis of pharmaceutical interventions performed in Spanish critical adults' care units.</p><p><strong>Method: </strong>Observational, prospective and multicenter study. In the first stage, a national registry of pharmaceutical interventions will be agreed upon and subsequently all the pharmaceutical interventions performed on adult patients admitted to Spanish CCUs during eight weeks will be recorded. Variables related to the type of CCU, the drug involved in the intervention, type of intervention (indication, effectiveness, safety), recommendation made by the pharmacist and the degree of acceptance will be evaluated. Risk and incidence will be calculated for each of the medication errors detected. The χ2-squared test or Fisher exact test will be used for categorical variables and Mann-Whitney U or Kruskal-Wallis test for continuous variables. All tests will be performed with a significance level α = 0.05 and confidence intervals with confidence 1- α.</p><p><strong>Discussion: </strong>The results obtained from this project will make it possible to obtain a homogeneous classification of the pharmaceutical interventions performed in CCU, a national record and an evaluation of the weak points with the aim of developing strategies for improvement in the pharmaceutical care of the critically ill patient.</p>","PeriodicalId":45860,"journal":{"name":"FARMACIA HOSPITALARIA","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"National record and analysis of pharmaceutical interventions in critical care units: PHARMACRITIC study.\",\"authors\":\"María Martín Cerezuela, Fernando Becerril Moreno, Miguel Ángel Amor García, Carla Bastida Fernández, Irene Aquerreta González, Sara Cobo Sacristán, Amaia Egüés Lugea, Marta Albanell Fernández, Laura Doménech Moral, Aurora Fernández Polo, Tatiana Betancor García, Sara Ortiz Pérez, Esther Domingo Chiva\",\"doi\":\"10.1016/j.farma.2024.05.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To design a homogeneous methodology for the registration and analysis of pharmaceutical interventions performed in Spanish critical adults' care units.</p><p><strong>Method: </strong>Observational, prospective and multicenter study. In the first stage, a national registry of pharmaceutical interventions will be agreed upon and subsequently all the pharmaceutical interventions performed on adult patients admitted to Spanish CCUs during eight weeks will be recorded. Variables related to the type of CCU, the drug involved in the intervention, type of intervention (indication, effectiveness, safety), recommendation made by the pharmacist and the degree of acceptance will be evaluated. Risk and incidence will be calculated for each of the medication errors detected. The χ2-squared test or Fisher exact test will be used for categorical variables and Mann-Whitney U or Kruskal-Wallis test for continuous variables. All tests will be performed with a significance level α = 0.05 and confidence intervals with confidence 1- α.</p><p><strong>Discussion: </strong>The results obtained from this project will make it possible to obtain a homogeneous classification of the pharmaceutical interventions performed in CCU, a national record and an evaluation of the weak points with the aim of developing strategies for improvement in the pharmaceutical care of the critically ill patient.</p>\",\"PeriodicalId\":45860,\"journal\":{\"name\":\"FARMACIA HOSPITALARIA\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2024-06-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"FARMACIA HOSPITALARIA\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.farma.2024.05.008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"FARMACIA HOSPITALARIA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.farma.2024.05.008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
摘要
目的设计一种统一的方法,用于登记和分析在西班牙重症成人护理病房实施的药物干预:观察性、前瞻性和多中心研究。在第一阶段,将商定一个全国药物干预登记册,随后将记录八周内对西班牙重症监护病房收治的成人患者实施的所有药物干预。将对与 CCU 类型、干预涉及的药物、干预类型(适应症、有效性、安全性)、药剂师建议和接受程度相关的变量进行评估。将计算所发现的每种用药错误的风险和发生率。分类变量将采用 χ2 平方检验或费雪精确检验,连续变量将采用 Mann-Whitney U 或 Kruskal-Wallis 检验。所有检验的显著性水平为 α = 0.05,置信区间为置信 1-α:该项目的研究结果将有助于对重症监护病房的药物干预进行统一分类,建立全国记录,并对薄弱环节进行评估,从而制定改善重症患者药物护理的策略。
National record and analysis of pharmaceutical interventions in critical care units: PHARMACRITIC study.
Objective: To design a homogeneous methodology for the registration and analysis of pharmaceutical interventions performed in Spanish critical adults' care units.
Method: Observational, prospective and multicenter study. In the first stage, a national registry of pharmaceutical interventions will be agreed upon and subsequently all the pharmaceutical interventions performed on adult patients admitted to Spanish CCUs during eight weeks will be recorded. Variables related to the type of CCU, the drug involved in the intervention, type of intervention (indication, effectiveness, safety), recommendation made by the pharmacist and the degree of acceptance will be evaluated. Risk and incidence will be calculated for each of the medication errors detected. The χ2-squared test or Fisher exact test will be used for categorical variables and Mann-Whitney U or Kruskal-Wallis test for continuous variables. All tests will be performed with a significance level α = 0.05 and confidence intervals with confidence 1- α.
Discussion: The results obtained from this project will make it possible to obtain a homogeneous classification of the pharmaceutical interventions performed in CCU, a national record and an evaluation of the weak points with the aim of developing strategies for improvement in the pharmaceutical care of the critically ill patient.
期刊介绍:
Una gran revista para acceder a los mejores artículos originales y revisiones de la farmacoterapia actual. Además, es Órgano de expresión científica de la Sociedad Española de Farmacia Hospitalaria, y está indexada en Index Medicus/Medline, EMBASE/Excerpta Médica, Alert, Internacional Pharmaceutical Abstracts y SCOPUS.